300142 沃森生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.3811.9691.5144.5508.295
总资产报酬率 ROA (%)0.9541.3270.9382.7125.023
投入资产回报率 ROIC (%)1.2211.8431.3914.1787.803

边际利润分析
销售毛利率 (%)68.46674.55879.69185.47488.018
营业利润率 (%)29.5277.7723.42614.92521.615
息税前利润/营业总收入 (%)29.8594.1214.51812.83519.807
净利润/营业总收入 (%)25.7785.1766.18112.43018.446

收益指标分析
经营活动净收益/利润总额(%)28.676187.298156.999160.534119.595
价值变动净收益/利润总额(%)-14.96519.392-50.576-38.004-17.519
营业外收支净额/利润总额(%)-1.642-13.14647.603-2.503-2.707

偿债能力分析
流动比率 (X)2.1622.3472.9822.7262.550
速动比率 (X)1.8822.0512.6642.4032.266
资产负债率 (%)29.78720.99521.84426.90128.340
带息债务/全部投入资本 (%)12.8311.6542.5894.1201.426
股东权益/带息债务 (%)644.9045,677.6193,603.8792,196.5716,535.940
股东权益/负债合计 (%)223.496340.186293.166222.946209.008
利息保障倍数 (X)36.901-1.500-2.236-7.437-15.997

营运能力分析
应收账款周转天数 (天)449.481339.054351.538292.173214.357
存货周转天数 (天)365.210388.159561.439611.627552.109